CARLSMED INC

CARLNASDAQ

🏆 #3177 by market capEarnings Nov 5US Equity

$921.42▲ $46.81 (+5.08%)

Simulated price

🔔

Track CARL

Get earnings, price moves & breaking news on Telegram

Track

24h▲ 5.1%

7d—

14d—

30d—

ytd—

1y—

🏦Market Cap

$385M

Small Cap

📈Revenue Growth (YoY)

+85.9%

High Growth

📊Gross Margin

76.6%

High

💵FCF Margin

-54.0%

Thin

⚖️P/S Ratio

6.1x

Fair

Otter Score

Good

No chart data available for CARL.

Trading Snapshot

Day Range: $917.90 – $934.50
52-Week Range: $8.50 – $17.23
Volume: $3.09B
Avg Volume: $3.91B
Shares Outstanding: 27.2M
Next Earnings: Dec 12, 2026

Fundamentals Snapshot

Annual Revenue: $51M
Last Q Revenue: $19M
P/E Ratio: -10.4
P/S Ratio: 6.1x
EPS (TTM): $-1.34
Dividend Yield: 0.00%
Dilution (1yr): −46.4%

Why Investors Own CARL

✓High-growth profile — revenue up +16.7% YoY with expanding US Equity exposure.
✓Healthy economics — 65% gross margin and 30% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CARLSMED INC

CARL

Financial Trends

Revenue

$51M▲ +85.9% YoY

Gross Margin

75.3%▲ +2.0% YoY

Operating Income

−$31M▲ +26.7% YoY

Free Cash Flow

−$30M▲ +15.5% YoY

Shares Outstanding

14.2M▼ −46.4% YoY

Net Cash

$68M▲ +$45M YoY

StockOtter · stockotter.space

About CARLSMED INC

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

🦦